NCF1 and central nervous system cancer: Additionally, Kaplan–Meier survival analyses confirmed the strong association between increased expression levels of NCF1, HSPB1, PIGT, PTX3, CCNA2, CCNB2, CCN4, and DES and poor prognostic outcomes in glioma patients.